InMode to Present at Upcoming Investor Conferences
Get Alerts INMD Hot Sheet
Join SI Premium – FREE
YOKNEAM,

Barclays 27th Annual Global Healthcare Conference
Presenters:
Format: In-person fireside chat moderated by
Location:
When: Wednesday, March 12 at
A live webcast of the presentation can be accessed here.
Oppenheimer 34th Annual Healthcare MedTech & Services Conference
Presenters: Moshe Mizrahy, Chief Executive Officer and
Format: Virtual fireside chat moderated by
When: Tuesday, March 18 at
A live webcast of the presentation can be accessed here.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Investor Relations Contact:
MS-IR LLC
[email protected]
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-upcoming-investor-conferences-302387848.html
SOURCE InMode Ltd.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Beyond the Credential: As AI Erases the 'Entry-Level Job' and Climate Volatility Accelerates, Planet Classroom Unveils July Lineup Mapping the New Rules of Human Resilience
- SK Telecom Pursues 15GW AI Data Center Buildout, Aiming to Become Asia's AI Infrastructure Hub
- Cunard's Queen Mary 2 Takes Centre Stage During America's 250th Anniversary Celebration in New York Harbour
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share